Cargando…

Recent advances in the understanding of Dupuytren’s disease

Dupuytren’s disease (DD) is a common fibrotic disorder of the hand and can significantly impair hand function. Although the exact pathogenesis of this disorder remains to be elucidated, immunological, genetic and cellular factors likely interact. In this review, we summarise recent advances in the u...

Descripción completa

Detalles Bibliográficos
Autores principales: Layton, Thomas, Nanchahal, Jagdeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396840/
https://www.ncbi.nlm.nih.gov/pubmed/30854193
http://dx.doi.org/10.12688/f1000research.17779.1
_version_ 1783399330500050944
author Layton, Thomas
Nanchahal, Jagdeep
author_facet Layton, Thomas
Nanchahal, Jagdeep
author_sort Layton, Thomas
collection PubMed
description Dupuytren’s disease (DD) is a common fibrotic disorder of the hand and can significantly impair hand function. Although the exact pathogenesis of this disorder remains to be elucidated, immunological, genetic and cellular factors likely interact. In this review, we summarise recent advances in the understanding of DD pathogenesis and look to the future for potential novel therapeutic targets. In addition, we discuss the therapeutic options in DD with a focus on the need for more rigorous evidence to allow a meaningful comparison of different treatment modalities.
format Online
Article
Text
id pubmed-6396840
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-63968402019-03-07 Recent advances in the understanding of Dupuytren’s disease Layton, Thomas Nanchahal, Jagdeep F1000Res Review Dupuytren’s disease (DD) is a common fibrotic disorder of the hand and can significantly impair hand function. Although the exact pathogenesis of this disorder remains to be elucidated, immunological, genetic and cellular factors likely interact. In this review, we summarise recent advances in the understanding of DD pathogenesis and look to the future for potential novel therapeutic targets. In addition, we discuss the therapeutic options in DD with a focus on the need for more rigorous evidence to allow a meaningful comparison of different treatment modalities. F1000 Research Limited 2019-02-28 /pmc/articles/PMC6396840/ /pubmed/30854193 http://dx.doi.org/10.12688/f1000research.17779.1 Text en Copyright: © 2019 Layton T and Nanchahal J http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Layton, Thomas
Nanchahal, Jagdeep
Recent advances in the understanding of Dupuytren’s disease
title Recent advances in the understanding of Dupuytren’s disease
title_full Recent advances in the understanding of Dupuytren’s disease
title_fullStr Recent advances in the understanding of Dupuytren’s disease
title_full_unstemmed Recent advances in the understanding of Dupuytren’s disease
title_short Recent advances in the understanding of Dupuytren’s disease
title_sort recent advances in the understanding of dupuytren’s disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396840/
https://www.ncbi.nlm.nih.gov/pubmed/30854193
http://dx.doi.org/10.12688/f1000research.17779.1
work_keys_str_mv AT laytonthomas recentadvancesintheunderstandingofdupuytrensdisease
AT nanchahaljagdeep recentadvancesintheunderstandingofdupuytrensdisease